First mammography screening participation and breast cancer incidence and mortality

This population-based cohort study evaluated the long-term relationship between initial participation in mammography screening and subsequent breast cancer outcomes among approximately 432,000 women in Stockholm, Sweden. Women were invited to their first screening between 1991 and 2020 at ages 40 or 50 and followed for up to 25 years through national health registries. Overall, 32% did not attend their initial screening. Non-attenders were significantly less likely to participate in later screening rounds and were more likely to be diagnosed with advanced disease, showing 1.5-fold higher odds of stage III and more than 3.5-fold higher odds of stage IV breast cancer compared with attenders. Although cumulative 25-year breast cancer incidence was similar between groups (7.6–7.8%), breast cancer–specific mortality was markedly higher among non-attenders (adjusted HR 1.40; 95% CI 1.26–1.55). These findings indicate that missing the first mammography screening is associated with delayed detection and worse survival, underscoring the importance of promoting early participation as a key strategy in population-based breast cancer.

Publication Details

Journal
CUNY Academic Works (City University of New York)
Published
2025-12-04
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First mammography screening participation and breast cancer incidence and mortality

CUNY Academic Works (City University of New York)
Global Cancer Incidence and Screening
article

First mammography screening participation and breast cancer incidence and mortality

article en

Abstract

This population-based cohort study evaluated the long-term relationship between initial participation in mammography screening and subsequent breast cancer outcomes among approximately 432,000 women in Stockholm, Sweden. Women were invited to their first screening between 1991 and 2020 at ages 40 or 50 and followed for up to 25 years through national health registries. Overall, 32% did not attend their initial screening. Non-attenders were significantly less likely to participate in later screening rounds and were more likely to be diagnosed with advanced disease, showing 1.5-fold higher odds of stage III and more than 3.5-fold higher odds of stage IV breast cancer compared with attenders. Although cumulative 25-year breast cancer incidence was similar between groups (7.6–7.8%), breast cancer–specific mortality was markedly higher among non-attenders (adjusted HR 1.40; 95% CI 1.26–1.55). These findings indicate that missing the first mammography screening is associated with delayed detection and worse survival, underscoring the importance of promoting early participation as a key strategy in population-based breast cancer.

CUNY Academic Works (City University of New York)
Good health and well-being
Openalex Percentile: Top 32%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.